Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus (Q60193818)

2

0 references

Elizabeth Clarke

3

0 references

Chunyan Ye

4

0 references

Bruno Pitard

on focus list of Wikimedia project

5

0 references

language of work or name

English

0 references

publication date

November 2018

0 references

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

0 references

volume

36

0 references

issue

46

0 references

page(s)

6911-6917

0 references

WikiProject Zika Corpus

0 references

cites work

Zika Virus in the Americas — Yet Another Arbovirus Threat

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

West Nile virus: review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

A global perspective on the epidemiology of West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

The burden of dengue infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

The Zika Pandemic - A Perfect Storm?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Zika virus is a global public health emergency, declares WHO

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Zika virus in the Americas: Early epidemiological and genetic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Flaviviruses and their antigenic structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

A structural perspective of the flavivirus life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Flaviviruses and flavivirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Vaccine protection against Zika virus from Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Rapid development of a DNA vaccine for Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Modified mRNA Vaccines Protect against Zika Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

A Nonionic Amphiphile Agent Promotes Gene Delivery In Vivo to Skeletal and Cardiac Muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Amphiphilic block copolymers promote gene delivery in vivo to pathological skeletal muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Therapy of anemia in kidney failure, using plasmid encoding erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

DNA/amphiphilic block copolymer nanospheres reduce asthmatic response in a mouse model of allergic asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium abscessus model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

MgtC as a Host-Induced Factor and Vaccine Candidate against Mycobacterium abscessus Infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

The 3.8 Å resolution cryo-EM structure of Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Phylogeny of Zika Virus in Western Hemisphere, 2015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Comprehensive Annotation of Mature Peptides and Genotypes for Zika Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

The flavivirus precursor membrane-envelope protein complex: structure and maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Structural Transition and Antibody Binding of EBOV GP and ZIKV E Proteins from Pre-Fusion to Fusion-Initiation State.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022

Polyvalent vaccine approaches to combat HIV-1 diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.10.022